Member Info for bamb

all-bran you do talk some rubbish, first you say a penny now you are saying it will go lower than current SP....stop picking on every share that has done a placing

eff off all-bran, every share is a dog to you

wonder why he's in London...

beat me to it :)))

well news definitely accepted as good...can now sell at 2.9. looking good

OK, experts....so change in dosing...is that a phase 1 or 2 trial? How long to check safety?

I hope (for the company's sake) there is no news with the interims given that any info they did have could/should have been shared earlier to arrest the decline or put us out of our misery...so chances it will be a case of reading way too much into Tim's words.

wait for the placing first

positive post Lambo! But if you wait until 8am to buy on good news....good luck on getting anything under 5p

sit and hold...could be days, weeks, months....next news will be the appointment of a third director

never underestimate the stupidity and patience of investors.

we have idea what they mean by significant. It's like when a CEO says news imminently and it ends up being months! Just saying FDA's idea of significant may not actually affect P3 much

I am hoping they have the balls to issue separate RNS's and not hope to hide any poor news inside the interims

it's tough as an investor but imagine how lupus sufferers feel with much time wasted on a drug that may actually work. you do wonder what is the point of FDA sometimes

if you have 10K to spend, you don't blow it on a lost cause

absolute joke that the business (minus cash) valued at 40mn....it is a joke right? Company PR really gone downhill....Come on Mo, show some fight

I agree, but I feel better and the SP is recovering this afternoon

guys, email the company. I received a reply earlier and feel more comfortable. I won't repeat what it said, it was nothing market sensitive but the tone reassuring.

Lambo, you are assuming the worst! Stop conjecting and stop comparing IMM to DDDD. Stop filling in the gaps with your pesimism. If it's over, fine...but right now, the decision could go any number of ways.

not be so dramatic dallo, but suggest those who care email the company
investors@immupharma.com